Union Budget 2026 boosts India’s biopharma ambitions: USAIC

BusinessIANS
Advertisement
Washington, Feb 2 : The annual Union Budget sends a clear policy signal on biopharma and healthcare innovation, the USA India Chambers of Commerce (USAIC) said, citing new investments, expansion of clinical trial infrastructure, and steps toward global regulatory alignment.

The government’s early focus on biopharma, including the Biopharma Shakti initiative and the plan to create 1,000 clinical trial sites nationwide, reflected a decisive push to move India up the global value chain in biopharma and healthcare innovation, USAIC president Karun Rishi told IANS.

He said the Rs 10,000 crore allocation to Biopharma Shakti over five years strengthened this commitment. While modest by global benchmarks, Rishi said the investment sent a strong policy signal and supported the development of a high-value, high-skill, and technology-driven biopharma ecosystem.

Rishi said the proposed nationwide network of 1,000 clinical trial sites was a particularly important step toward strengthening India’s clinical research infrastructure.

“For over two decades, USAIC has consistently emphasised the importance of capacity building, skill development, and the expansion of ethical, high-quality clinical trials as foundational to India’s emergence as a global biopharma innovation leader,” he said.

He said the announcement reflected meaningful alignment between long-standing industry engagement and government policy action.

Rishi also welcomed the government’s intent to strengthen and restructure the Central Drugs Standard Control Organization in line with global standards and benchmarks.

He said credible regulation, science- and evidence-based decision-making, and predictable approval timelines were essential for global competitiveness in pharmaceuticals.

These priorities, he said, were strongly articulated during USAIC’s BioPharma Strategy Session in Delhi last December, including discussions with NITI Aayog leadership and senior government officials.

Beyond the pharma sector, Rishi said Budget 2026 stood out as a confident, forward-looking statement anchored in growth, inclusion, and fiscal prudence amid heightened global geopolitical and economic uncertainty.

He said the government had stayed the course on macroeconomic stability while doubling down on skills, employability, research, science, and innovation.

Rishi said this sent a clear signal that India’s growth story would be innovation-led and future-ready, even as execution would remain the true test.

USAIC commended the Finance Minister and the Government of India for what it described as decisive measures across strategic sectors.

Observing that restructuring of the CDSCO is central to global regulatory alignment, Rishi said India should now consider transitioning from observer to full member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, which is consistent with India’s scientific capabilities and manufacturing scale.

He said Budget 2026 marked an important inflection point and that sustained and effective implementation could firmly anchor India’s position on the global biopharma innovation map.
Advertisement

Note: The content of this article is sourced from a news agency and has not been edited by the ap7am team.

USAICUnion Budget 2026Biopharma ShaktiKarun RishiIndia biopharmahealthcare innovationclinical trials IndiaCDSCO restructuringpharmaceutical regulation

More News

BRS leader Harish Rao accuses Congress of 'unkept promises'

17 Nov, 11:57

‘Akvan’ set to intensify into severe cyclone by evening; Andhra CM takes stock of situation

17 Nov, 11:24

Six Pakistani soldiers killed in 4 drone Ops across Balochistan: BLA

17 Nov, 11:09

13 killed in three separate road accidents in Uttarakhand; CM Dhami expresses grief

17 Nov, 11:03

Rupee gains 31 paise against US dollar amid falling crude oil prices

17 Nov, 10:41

Gas leak from ONGC well in Andhra’s Konaseema district triggers panic

17 Nov, 10:39

'Seven batters, four pacers': Gill reveals India's combinations for Test series opener vs NZ

17 Nov, 10:35

Different religions don't have equal place in American identity: US preacher

17 Nov, 10:20

Two public safety officers shot in New York; gunman found dead

17 Nov, 10:11

Former India Caucus co-chair Jim McDermott dies at 89

17 Nov, 10:10

Third US aircraft carrier arrives in Middle East amid Iran tensions

17 Nov, 10:09

Vance says Trump will avoid ‘forever war’ in Iran

17 Nov, 10:08

US court strikes down fixed stay rule for international students, exchange visitors

17 Nov, 10:07

Iran says another 'violating' oiler caught fire in Hormuz, denies air defence activity in central province

17 Nov, 10:05

US touts truck-driver crackdown as safety gain

17 Nov, 09:50

2027 UP polls: SP, Cong to hold seat-sharing negotiations in Delhi today

17 Nov, 09:49

Indian American Congressman seeks $1,700 Iran war refund for families

17 Nov, 08:59

US Senate bill seeks to withhold $33 million Pakistan aid until Shakil Afridi's release

17 Nov, 08:58

PM Modi to attend ASEAN-India, East Asia summits in Manila today

17 Nov, 08:56

California's Hindu temple reports new break-in

17 Nov, 08:56
..More News